Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Understand what the zero-based budgeting method is and how it can help you control your spending. This approach optimizes your finances.
15,911 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
When a mid-size firm makes a bold move into quantum tech, the market watches closely. This piece breaks down what Try...
When an executive sells stock, investors ask whether it signals trouble or simply personal liquidity needs. This guid...
A new AI risk assessment shows programmers face high displacement risk, upending traditional SaaS models and pressuri...
Is the Trump bull market about to end, or is this a chapter in a longer market cycle? This guide blends history, data...
Markets edged lower in March as crypto regulation chatter intensified. Circle CRCL led the headlines with a sharp mov...
The Trade Desk has faced a tough stretch, but patient investors are asking if the trade desk stock finally offers a p...
Q1 2026 dumped new data on the health tech landscape, revealing who’s thriving, where margins are headed, and how to ...
As headlines shout about dwindling oil, some stocks stand out no matter the price: upstream producers ride price cycl...
AI-driven power demand is reshaping the clean-energy landscape, and Bloom Energy is at the center of the move. This g...
Promotional sign up offers can turbocharge your rewards, but they’re easy to misread. This expert guide breaks down h...
As quantum computers edge closer to practical power, Algorand faces a pivotal challenge. This article breaks down how...